Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Operating activities:    
Net income $ 6,397 $ 4,005
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 986 927
Amortization 113 113
Amortization of unrecognized prior service cost and actuarial losses 442 444
Discount accretion on investments (4) (6)
Stock-based compensation expense 342 319
Loss on disposal of property, plant and equipment   (1)
Deferred income taxes 220 (58)
(Increase) decrease in operating assets:    
Accounts receivable (4,596) 40
Unbilled revenue 3,640 2,909
Inventories 139 (3,623)
Prepaid expenses and other current and non-current assets (457) (145)
Prepaid pension asset (397) (384)
Increase (decrease) in operating liabilities:    
Accounts payable (1,938) 2,233
Accrued compensation, accrued expenses and other current and non-current liabilities 135 35
Customer deposits (1,343) (1,765)
Income taxes payable/receivable 568 1,186
Long-term portion of accrued compensation, accrued pension liability and accrued postretirement benefits 46 15
Net cash provided by operating activities 4,293 6,244
Investing activities:    
Purchase of property, plant and equipment (898) (578)
Proceeds from disposal of property, plant and equipment   4
Purchase of investments (54,997) (33,494)
Redemption of investments at maturity 50,500 27,500
Net cash used by investing activities (5,395) (6,568)
Financing activities:    
Principal repayments on capital lease obligations (44) (41)
Issuance of common stock 259 14
Dividends paid (603) (399)
Excess tax benefit (deficiency) on stock awards 119 (5)
Net cash used by financing activities (269) (431)
Effect of exchange rate changes on cash 39 (11)
Net decrease in cash and cash equivalents (1,332) (766)
Cash and cash equivalents at beginning of period 24,194 25,189
Cash and cash equivalents at end of period $ 22,862 $ 24,423